Nuvectis Pharma Inc Financial Flexibility Index
Nuvectis Pharma Inc financial flexibility index. Nuvectis Pharma Inc (NVCT) has a Financial Flexibility Index of -0.34x as of June 2026. Free cash flow of $-4.53 Million (operating CF $-4.53 Million minus capex $0.00) represents 0% of total liabilities ($13.29 Million). See Nuvectis Pharma Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Nuvectis Pharma Inc (2020–2025)
Financial flexibility index of Nuvectis Pharma Inc from 2020 to 2025. Historical Financial Flexibility Index trend for Nuvectis Pharma Inc across 6 annual periods. Explore debt repayment capacity of Nuvectis Pharma Inc to assess how comfortably operating cash covers total debt obligations.
Nuvectis Pharma Inc Financial Flexibility Index by Year (2020–2025)
Nuvectis Pharma Inc financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for Nuvectis Pharma Inc. For the full cash flow conversion analysis, see NVCT cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.20x | $-16.01 Million | $-16.01 Million | $13.30 Million | ▲ +12.6% |
| 2024 | -1.38x | $-12.25 Million | $-12.25 Million | $8.89 Million | ▲ +39.7% |
| 2023 | -2.28x | $-15.95 Million | $-15.95 Million | $6.98 Million | ▼ -4.2% |
| 2022 | -2.19x | $-13.56 Million | $-13.56 Million | $6.19 Million | ▼ -307.4% |
| 2021 | -0.54x | $-9.50 Million | $-9.50 Million | $17.66 Million | ▼ -122.4% |
| 2020 | 2.40x | $24.00K | $24.00K | $10.00K | — |